We've found
						451
						 archived clinical trials in
						Rheumatology
					
				We've found
						451
						 archived clinical trials in
						Rheumatology
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
	
	A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
	
Updated: 12/31/1969
  
  
  	  A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
	
	Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
	
Updated: 12/31/1969
  
  
  	  A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects With Active Sjogren's Syndrome
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home
	
Updated: 12/31/1969
  
  
  Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home
		Status: Enrolling	
	Updated: 12/31/1969
	
	Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home
	
Updated: 12/31/1969
  
  
  	  Integration of Musculoskeletal Physical Therapy Care in the Patient Centered Medical Home
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk Population
	
Updated: 12/31/1969
  
  
  Oral Health Needs Assessment of Sjogren's Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers - Evaluating Oral Health Disparities as Determinants of Oral Health in a High-risk Population
		Status: Enrolling	
	Updated: 12/31/1969
	
	Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk Population
	
Updated: 12/31/1969
  
  
  	  Oral Health Needs Assessment of Sjogren's Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers - Evaluating Oral Health Disparities as Determinants of Oral Health in a High-risk Population
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
	
Updated: 12/31/1969
  
  
  Patients to People: Examining the Effects of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes in Medical Students. A Qualitative Study
		Status: Enrolling	
	Updated: 12/31/1969
	
	Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
	
Updated: 12/31/1969
  
  
  	  Patients to People: Examining the Effects of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes in Medical Students. A Qualitative Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
		    
			
	Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17
	
Updated: 12/31/1969
  
  
  Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17, Demonstration of Double-blind Trial Results
		Status: Enrolling	
	Updated: 12/31/1969
	
	Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17
	
Updated: 12/31/1969
  
  
  	  Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17, Demonstration of Double-blind Trial Results
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials